Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00899301 · ClinicalTrials.gov registry record

Collecting and Storing Tissue Samples From Women With or Without Breast Cancer

A clinical trial of Breast Cancer, sponsored by Vanderbilt-Ingram Cancer Center.

Recruiting
Registry status
4,000
Enrollment target
1
Study location

NCT00899301 is a study of Breast Cancer that is actively recruiting participants, run by Vanderbilt-Ingram Cancer Center. The registered enrollment target is 4,000 participants, above the 2,800-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (43% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00899301, a study of Breast Cancer, is actively recruiting participants, sponsored by Vanderbilt-Ingram Cancer Center.

RECRUITING
Registry status
4,000 participants
Enrollment target
1
Study location

Study Summary

RATIONALE: Collecting and storing samples of tissue, blood, and urine from patients with or without breast cancer to study in the laboratory may help the study of cancer. PURPOSE: This research study is collecting and storing tissue samples from women with or without breast cancer.

Conditions Studied

Interventions

  • OTHER biologic sample preservation procedure

Study Locations (1)

Tennessee

  • Vanderbilt-Ingram Cancer Center - Nashville

Trial Details

FieldValue
Enrollment Target 4,000 participants
Start Date 2004-01-22
Est. Completion 2027-03

Sponsor

Vanderbilt-Ingram Cancer Center

189 total trials

What the Registry Record Tells You About NCT00899301

The ClinicalTrials.gov registry entry for NCT00899301 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 4,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 2,800-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (43% higher). The listed sponsor is Vanderbilt-Ingram Cancer Center, which has 189 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Breast Cancer appearing as the primary indexed condition, and to 1 intervention - of which biologic sample preservation procedure is the first listed.

NCT00899301 reports 1 study location spanning 1 distinct geographic area - top geographies include Tennessee.

Frequently Asked Questions

What is clinical trial NCT00899301 about?

NCT00899301 is a clinical study titled "Collecting and Storing Tissue Samples From Women With or Without Breast Cancer". RATIONALE: Collecting and storing samples of tissue, blood, and urine from patients with or without breast cancer to study in the laboratory may help the study of cancer. PURPOSE: This research study is collecting and storing tissue samples from women with or without breast cancer.

What is the current status of trial NCT00899301?

This trial is currently recruiting. The enrollment target is 4,000 participants. The study started on 2004-01-22. Estimated completion is 2027-03.

What conditions does trial NCT00899301 study?

This clinical trial studies the following conditions: Breast Cancer.

What interventions are being tested in trial NCT00899301?

The interventions under investigation include: biologic sample preservation procedure (OTHER).

Who is sponsoring clinical trial NCT00899301?

This trial is sponsored by Vanderbilt-Ingram Cancer Center, which has 189 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00899301 being conducted?

This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Breast Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.